CG-202

N/A

Report date: 2022/05/10 11:38:35

NME

Base Information

Drug NameCG-202

Drug Alias NameCG202

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBromodomain-containing protein 2 inhibitors

TargetsBromodomain-containing protein 2

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesConverGene LLC

China Registration ClassN/A

Active CompaniesConverGene LLC

Inactive CompaniesN/A

Active IndicationsHematologic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A